Published in Gene Therapy Weekly, July 1st, 2004
The patent, titled "Suppression of Malignancy Utilizing Ribonucleotide Reductase R1," protects an innovative approach to inhibiting tumor growth in mammals, including humans. Using a vector delivery system, a tool of gene therapy, the tumor suppressor gene sequence is delivered to cancer cells and the resulting expression of the gene inhibits tumor growth.
Preclinical studies demonstrated markedly suppressed tumor growth. The gene can...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.